To provide optimal patient care, clinicians must be prepared with a comprehensive understanding of the appropriate treatment and management of patients with la/mUC and the clinical utility of agents that could significantly impact patient outcomes. As novel therapeutic regimens continue to enter the first-line setting, clinical decision-making and treatment sequencing will become increasingly complex, underscoring a need for CE. To successfully integrate novel therapies into practice and drive sustainable patient outcomes, clinicians caring for veterans withing the VA health system need to stay abreast of the latest clinical trial data and evidence-based guidelines, along with strategies for implementing optimal multidisciplinary care coordination and AE management.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 384 Inverness Parkway
Pricing
All courses included · from $18.75/mo
Courses are included in the subscription; some are also sold individually.
| Student Flex | $18.75/mo |
| Professional Flex | $60/mo |
| Student 3-Year | $100 |
| Student 2-Year | $112.50 |
+4 more plans
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Maternal-Fetal Medicine
- Medical Leadership & Administration
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Surgical Oncology
- Thoracic Anesthesia
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedDec 22, 2025
-
Last day to claim creditDec 23, 2026 2 months left
-
Answers in CME Inc. (AiCME) Advancing Holistic First-Line Care in Advanced Urothelial Carcinoma: Guideline-Based Strategies and Best Practices in AE Management
-
Medscape, LLC Redefining Locally Advanced/Metastatic Urothelial Carcinoma Care: The Impact of Updated Guidelines on the Community Oncology Practice
-
AXIS Medical Education, Inc. Reframing First-Line and Sequenced Care in Advanced Urothelial Carcinoma: Clinical Implications of the Updated NCCN Guideline Format
-
Plexus Communications +1 AKT Pathway Targeting in Metastatic Hormone-Sensitive Prostate Cancer: Practical Insights for VA Clinicians
-
Plexus Communications +1 Targeting EGFR in NSCLC: Evidence-Based Strategies Across Stages, Sequencing, and Resistance in Veterans Health Administration Practice Settings
-
Plexus Communications +1 Navigating Transformations in the Squamous, Non-Small Cell Lung Cancer Treatment Landscape: Implications for VA Healthcare Systems
